S100A8 and S100A9 in inflammation and cancer

被引:605
|
作者
Gebhardt, Christoffer [1 ]
Nemeth, Julia [1 ]
Angel, Peter [1 ]
Hess, Jochen [1 ]
机构
[1] German Canc Res Ctr, Div Signal Transduct & Growth Control, D-69120 Heidelberg, Germany
关键词
S100; RAGE; AP-1; NF-kappa B; inflammation; carcinogenesis;
D O I
10.1016/j.bcp.2006.05.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Calprotectin (S100A8/A9), a heterodimer of the two calcium-binding proteins S100A8 and S100A9, was originally discovered as immunogenic protein expressed and secreted by neutrophils. Subsequently, it has emerged as important pro-inflammatory mediator in acute and chronic inflammation. More recently, increased S100A8 and S100A9 levels were also detected in various human cancers, presenting abundant expression in neoplastic tumor cells as well as infiltrating immune cells. Although, many possible functions have been proposed for S100A8/A9, its biological role still remains to be defined. Altogether, its expression and potential cytokine-like function in inflammation and in cancer suggests that S100A8/A9 may play a key role in inflammation-associated cancer. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1622 / 1631
页数:10
相关论文
共 50 条
  • [21] S100A8 and S100A9 in Cardiovascular Biology and Disease
    Averill, Michelle M.
    Kerkhoff, Claus
    Bornfeldt, Karin E.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (02) : 223 - 229
  • [22] S100A8/S100A9 and their association with cartilage and bone
    H. Zreiqat
    C. R. Howlett
    S. Gronthos
    D. Hume
    C. L. Geczy
    [J]. Journal of Molecular Histology, 2007, 38 : 381 - 391
  • [23] S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
    Liao, Wei-Chih
    Chen, Chih-Ta
    Tsai, You-Shu
    Wang, Xin-Ya
    Chang, Yen-Tzu
    Wu, Ming-Shiang
    Chow, Lu-Ping
    [J]. BMC CANCER, 2023, 23 (01)
  • [24] S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
    Wei-Chih Liao
    Chih-Ta Chen
    You-Shu Tsai
    Xin-Ya Wang
    Yen-Tzu Chang
    Ming-Shiang Wu
    Lu-Ping Chow
    [J]. BMC Cancer, 23
  • [25] Regulation of myeloid cell differentiation by S100A8 and S100A9
    Defrene, J.
    Laouedj, M.
    Cesaro, A.
    Page, N.
    Barabe, F.
    Tessier, P.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 322 - 322
  • [26] Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1
    Basso, Daniela
    Bozzato, Dania
    Padoan, Andrea
    Moz, Stefania
    Zambon, Carlo-Federico
    Fogar, Paola
    Greco, Eliana
    Scorzeto, Michele
    Simonato, Francesca
    Navaglia, Filippo
    Fassan, Matteo
    Pelloso, Michela
    Dupont, Sirio
    Pedrazzoli, Sergio
    Fassina, Ambrogio
    Plebani, Mario
    [J]. CELL COMMUNICATION AND SIGNALING, 2014, 12 : 12 - 20
  • [27] Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1
    Daniela Basso
    Dania Bozzato
    Andrea Padoan
    Stefania Moz
    Carlo-Federico Zambon
    Paola Fogar
    Eliana Greco
    Michele Scorzeto
    Francesca Simonato
    Filippo Navaglia
    Matteo Fassan
    Michela Pelloso
    Sirio Dupont
    Sergio Pedrazzoli
    Ambrogio Fassina
    Mario Plebani
    [J]. Cell Communication and Signaling, 12
  • [28] S100A8 and S100A9 positive cells in colorectal carcinoma
    Bassorgun, C. I.
    Ozluk, A.
    Erin, N.
    Uzun, O. C.
    Elpek, G. O.
    [J]. VIRCHOWS ARCHIV, 2013, 463 (02) : 209 - 209
  • [29] SenoIndex: S100A8/S100A9 as a novel aging biomarker
    Zhang, Baohu
    Yan, Haoteng
    Liu, Xiaoqian
    Sun, Liang
    Ma, Shuai
    Wang, Si
    Qu, Jing
    Liu, Guang-Hui
    Zhang, Weiqi
    [J]. LIFE MEDICINE, 2023, 2 (04):
  • [30] S100A8 and S100A9: New Insights into Their Roles in Malignancy
    Srikrishna, Geetha
    [J]. JOURNAL OF INNATE IMMUNITY, 2012, 4 (01) : 31 - 40